Company attributes
Venture Capital Firm attributes
Other attributes
Latterell Venture Partners is a venture capital firm that seeks to invest in the in early-stage healthcare firms, including biotechnology, pharmaceutical, research instrument, biomaterial, medical device, healthcare technology and diagnostic ventures. The firm was founded in 2001 and is headquartered in San Ramon, California.
Latterell Venture Partners invests in early stage healthcare companies with innovative technologies, large market opportunities, and passionate entrepreneurs. They offer a blend of venture capital, entrepreneurial, technical, clinical and collaborative skills which enable them to help entrepreneurs grow their companies. Latterell Venture Partners is committed to building a portfolio of outstanding biotechnology and medical device companies which produce excellent returns for their limited partners while providing major new disease treatments to help patients worldwide.
Latterell Venture Partners' investments include Viracta Therapeutics, Neuraltus Pharmaceuticals, Aptinyx, Naurex, Transcend Medical, Pulmonx, Transcend Medical, Inova Labs, and TetraLogic Pharmaceuticals.
They have exited investments in Aptinyx, Transcend Medical, OncoMed Pharmaceuticals, Inova Labs, Naurex, TetraLogic Pharmaceuticals, CellBiosciences and Calistoga Pharmaceuticals.
